What are peptides?
Peptides are short chains of amino acids joined by peptide bonds. Amino acids are the building blocks of proteins, so peptides can be loosely thought of as small molecular "signals".
Many peptides occur naturally in the body and help regulate metabolism, hormonal processes, the immune response, appetite, growth and tissue repair, and signalling between cells. It is precisely their ability to interact with specific biological targets that made peptides interesting to pharmacology.
How do peptides work?
A simplified picture: a peptide binds to a particular biological target (a receptor, an enzyme or another protein) → it changes a signal → the body changes a particular process.
When developing medicines, the structure of a natural peptide may be modified — to make it more stable, extend how long it acts, or improve how it interacts with the intended target. For example, semaglutide acts on the GLP-1 receptor, which makes it possible to influence the regulation of blood glucose and appetite — and this is the basis for Ozempic.
Peptides that became medicines
Peptide medicines have existed for decades — one of the most important historical examples is insulin. Today peptide drugs are used for diabetes, obesity, bone disease, endocrine disorders, some cancers and other conditions: Ozempic, Wegovy, Rybelsus (semaglutide), Mounjaro, Zepbound (tirzepatide), Victoza, Saxenda (liraglutide), Trulicity (dulaglutide), Forteo (teriparatide), Sandostatin (octreotide), Lupron (leuprolide).
An example of one substance's regulatory path — semaglutide (Ozempic):
Takeaway: "peptide" is not a synonym for "experimental substance". Some peptides have gone through the full approval process and become ordinary prescription medicines. But the fact that a peptide is biologically active does not, on its own, mean that a particular substance has followed the same path.
The most discussed peptides that are not approved medicines
A separate group of peptides is popular in research, sports and wellness circles but is not approved (or not fully approved) as a medicine for the use in question:
This describes expectations and reasons for interest, not proven or guaranteed effects. For each peptide, a separate page on this site covers animal studies, human data, clinical cases, risks and what is still unknown.
Why many peptides never become medicines
Creating a new medicine is a process that takes many years: preclinical research, formulation development, manufacturing to required standards, several phases of clinical trials, and approval. It takes years and large investments, which can only pay off with patent protection.
If a molecule has been known for a long time, is hard to protect with a patent or is easy to synthesise, the commercial case for full development weakens — even if the substance is biologically interesting. A standard patent lasts 20 years from the filing date, while development and trials can take more than 10 years — so a large part of the patent term passes before the drug even reaches the market.
Why doctors advise against taking unapproved peptides
The peptide has not completed the full testing process. The full drug development cycle involves more than 10 years of laboratory, preclinical and clinical testing. For many popular peptides, that volume of data simply does not exist.
Long-term consequences are unknown. Good tolerability now does not tell us what will happen after several years of regular use.
Uncertain composition. Outside the pharmacy system there is no guarantee that the vial contains the stated substance, at the stated concentration and free of impurities.
Interference with the hormonal system. Some peptides (especially those related to growth hormone) change how the endocrine system works — doctors draw a parallel with anabolic steroids.
Better-studied alternatives exist. If there is an approved medicine with proven efficacy, it is simpler and safer for a doctor to recommend that.
A personal positive experience is not proof of efficacy. Training, diet, sleep and other medications all affect how a person feels at the same time — the effect of a particular peptide cannot be isolated from one person's subjective impressions.
Why other doctors do not see taking peptides as clearly a problem
Research data exist — even if not always enough for approval: laboratory studies, animal studies and, in some cases, human studies.
"Not approved" ≠ "does not work". Every medicine in use today was once an experimental substance.
Regulators themselves allow controlled access to unapproved substances in certain situations — for example, for seriously ill patients without good alternatives.
Many years of practical use. Some peptides have been used by many people over many years, and reports of serious problems remain relatively rare. Supporters of this view see this as indirect evidence that the risks doctors warn about are not as large in practice, although they are not zero.
The limitation of this argument: substances sold outside the pharmacy system usually have no organised collection of adverse-event data (pharmacovigilance) — so a small number of publicly known problems may reflect a lack of systematic monitoring rather than genuine safety. This does not refute the argument, but it explains why some doctors treat it with caution.
Some patients may have no good alternatives — in that case a doctor may look more closely at promising but not yet approved approaches.
Peptides have repeatedly become fully fledged medicines (semaglutide, tirzepatide, liraglutide, insulins) — the path "from experimental substance to medicine" does work for peptides in principle.
Both views coexist in the medical community, and we deliberately present them side by side without taking sides. On the page for each peptide we aim to show the same: the regulators' position where one exists, research data, real reports from people who have used it — with links to the source, possible effects and risks, contraindications and individual clinical cases. The materials on this site do not replace a consultation with a doctor and are not a recommendation to buy or use any substance.